Acetylcholinesterase inhibitors were suitable for all MG patients, except those undergoing cholinergic crisis, and may significantly reduce muscle weakness and impede AchR repair; therefore, they should not be used as a single agent in the long term. Here, ACHE is linked to myasthenia gravis.